Product Information

ALLOPURINOL 100 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.0322 per EA under NDC 70710120901. Its NADAC has been published 435 times since Jul 25, 2018.

FDA first approved this application on Oct 12, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Allopurinol market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

ALLOPURINOL 100 MG TABLET

Allopurinol
$0.0322per EA
High Outlier

Strength

100 mg/1

NDC

70710120901

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

ALLOPURINOL

Approval Type

Generic (ANDA)

FDA Application

ANDA210117

FDA Approved

10/12/2017

TE Code

AB

On Market Since

2/8/2018

Pharmacological Classes

Xanthine Oxidase Inhibitor
Xanthine Oxidase Inhibitors

Price Statistics

The NADAC for ALLOPURINOL 100 MG TABLET has been published 435 times since Jul 25, 2018, and over the history we have for it it has declined 68.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0322 per EA
All-time high$0.1030 (Aug 15, 2018)
All-time low$0.0312 (Oct 21, 2026)
52-week high$0.0366
52-week low$0.0312
Median price$0.0513
Average price$0.0558
Largest weekly change-28.6% (Nov 20, 2024)
Weeks tracked435
Tracking sinceJul 25, 2018

Price History

1W

+3.1%

1M

+2.0%

3M

+1.5%

6M

-3.6%

1Y

-11.9%

3Y

-34.7%

5Y

-44.8%

All

-68.8%

Generic Alternatives

The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ALLOPURINOL 100 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ALLOPURINOL 100 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.0322 per EA (NDC 70710120901), effective Nov 18, 2026.

How has the price of ALLOPURINOL 100 MG TABLET changed over time?

Over the history we have for it, the NADAC for ALLOPURINOL 100 MG TABLET has declined 68.8%. It has been tracked across 435 weekly CMS publications since Jul 25, 2018.

What are the highest and lowest recorded NADAC prices for ALLOPURINOL 100 MG TABLET?

Since Jul 25, 2018, the NADAC for ALLOPURINOL 100 MG TABLET has ranged from a low of $0.0312 (Oct 21, 2026) to a high of $0.1030 (Aug 15, 2018), with a median of $0.0513 per EA.

Are there cheaper alternatives to ALLOPURINOL 100 MG TABLET?

Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ALLOPURINOL 100 MG TABLET, is $0.0317 per EA — about 1% below ALLOPURINOL 100 MG TABLET.

Who manufactures ALLOPURINOL 100 MG TABLET?

ALLOPURINOL 100 MG TABLET (NDC 70710120901) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.